Long-term effects of inhaled Tobramycin on bronchiectasis patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ERASE II study is a prospective observational study that aims to evaluate the long-term impact of successfully eradicating Pseudomonas aeruginosa in patients with bronchiectasis. Following an initial 9-month period of the ERASE study, this study will extend observation for an additional 27 months to assess various outcomes such as quality of life, lung function, and frequency of pulmonary exacerbations. The study will also monitor the incidence of reinfections with Pseudomonas aeruginosa, providing insights into the long-term benefits of eradication therapy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* all patients who participate the ERSE study
* write the informed consent form.

Exclusion Criteria:

* patients who were lost of follow up in the ERASE study
* ineligible for inclusion at the discretion of the researcher for other reasons.

Where it's running

• Anhui Chest Hospital
  Hefei, Anhui, China Recruiting
• The First Affiliated Hospital of Anhui Medical University
  Hefei, Anhui, China Recruiting
• Beijing Chao-Yang Hospital, Capital Medical University
  Beijing, Beijing Municipality, China Recruiting
• Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
  Beijing, Beijing Municipality, China Recruiting
• The Third Affiliated Hospital of Chongqing Medical University
  Chongqing, Chongqing Municipality, China Recruiting
• Fujian Provincial Hospital
  Fuzhou, Fujiang, China Recruiting

+8 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Principal investigator: Jin-Fu Xu, PhD — Huadong Hospital affiliated with Fudan University
• Study coordinator: Jin-Fu Xu
• Email: jfxucn@163.com
• Phone: +8613321922898

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CTX-187 first-in-human test in healthy people and people with chronic bronchiectasis and Pseudomonas infection

  This study tests CTX-187 to see if it is safe and tolerable when given as IV infusions to healthy adults and adults with chronic bronchiectasis and Pseudomonas aeruginosa infection.

  Recruiting Phase 1 Centauri Therapeutics Limited · Groningen · NCT07708116

• Tele-Pulmonary Rehabilitation for Chronic Lung Diseases

  This study tests whether a remote tele-rehabilitation program helps people with chronic lung diseases start and stick with pulmonary rehab better than usual center-based care.

  Recruiting at 2 sites Tel-Aviv Sourasky Medical Center · Ashkelon and 1 other locations · NCT07666841

• Azithromycin added to usual care to see if it lowers bronchiectasis flare-ups

  This trial tests whether taking azithromycin daily for a year reduces bronchiectasis-related flare-ups in adults with non-cystic fibrosis bronchiectasis.

  Recruiting Phase 4 Assiut University · Asyut · NCT07608328

• Wearable sensors and AI to detect chest infection flare-ups in adults with cystic fibrosis or bronchiectasis

  This study will try wearable sensors and AI to see if changes in breathing or heart rate can spot chest infection flare-ups early in adults with cystic fibrosis or bronchiectasis who are starting IV antibiotics.

  Recruiting Papworth Hospital NHS Foundation Trust · Cambridge, Cambridgeshire · NCT07289100

• Home use of the LibAirty airway clearance system for adults with bronchiectasis

  This project will see if using the LibAirty airway clearance system at home reduces pulmonary exacerbations and improves symptoms for adults with bronchiectasis.

  Recruiting at 3 sites Synchrony-Medical, Ltd · Birmingham, Alabama and 2 other locations · NCT07135284

• Autologous Basal Layer Stem Cells to Treat Bronchiectasis

  Researchers will test autologous basal layer stem cells delivered through the airways to see if they can safely improve lung tissue in adults with bronchiectasis.

  Recruiting at 2 sites Phase 1 Ruijin Hospital · Qionghai, Hainan and 1 other locations · NCT06987214

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.